Mersana Therapeutics, Inc.: accounts_payable
| Value | {"amount": 7159000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-06-30) |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/dde703a4-9b6c-49f7-b848-05f38d5362a2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-20-012099Retrieved: 2026-08-19T14:14:31.671154+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/accounts-payable/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/dde703a4-9b6c-49f7-b848-05f38d5362a2
History
- no predecessors — first report